Nuventra was founded in 2008 by Geoffrey Banks, Ph.D., under the name ClinPharm Consulting, LLC. Dr. Banks formed a strategic partnership with Bill Wargin, Ph.D., who is a leading pharmacokinetic consultant, and together they created the foundation for the company’s growth.
Drs. Banks and Wargin realized that they had an extraordinary opportunity to create a consulting organization focused on an area of unmet need in the industry – clinical pharmacology and PK/PD. In developing the business paradigm, they recognized the benefits of having a team of industry veterans available for clients to address complex issues in clinical pharmacology and PK. In 2009, M. Alexander Shaw, Ph.D., joined as a full partner and became the COO. In 2013, the company name changed to Nuventra Pharma Sciences.
Since the company was founded, it has grown exponentially, now with more than 50 scientific consultants. The company has been listed on the Inc. 5000 list of fastest growing companies for four straight years. Nuventra was recently a recipient of the Triangle Business Journal Fast 50 award. While the company’s roots remain planted in clinical pharmacology and PK/PD, services have expanded into other infrastructure and capabilities including clinical operations and management.